Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clinique Spécialisée en Allergie de la Capitale (CSAC) is a leading medical clinic and clinical research center based in Quebec City, Canada, specializing in immuno-allergy. Originally founded in 1983 as the Centre de Recherche Appliquée en Allergie de Québec (CRAAQ), the center rebranded in 2014 and continues to provide expert diagnostic and treatment services for both pediatric and adult patients. The clinic offers a wide range of services, including skin testing, oral food challenges, and allergen immunotherapy for conditions such as asthma, food allergies, and chronic urticaria. Beyond its clinical practice, CSAC is a prominent site for Phase II-IV clinical trials, collaborating with global pharmaceutical companies to advance treatments for respiratory and allergic diseases. The facility is equipped with specialized infrastructure to conduct high-standard clinical research while providing patient care covered by the Quebec health insurance plan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clinique Spécialisée en Allergies de la Capitale.